Q2 saw record room openings and a robust development pipeline, with U.S. RevPAR up 2% and adjusted EBITDA and EPS each rising 3% on a comparable basis. Guidance was raised for U.S. and global RevPAR, while strong cash flow supported significant shareholder returns and continued investment in technology and loyalty programs.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.